Multiple Assemblies exist for SMTL entry 8c3v
SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody; X-RAY DIFFRACTION 2.74 Å

	SMTL ID 8c3v.1 Ligands alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose; GLYCEROL; 2-(2-METHOXYETHOXY)ETHANOL Polypeptides BA.2-13 heavy chain; BA.2-13 light chain; Spike protein S1; Nanobody C1 Oligo-state hetero-1-1-1-1-mer
	SMTL ID 8c3v.2 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose; GLYCEROL; TETRAETHYLENE GLYCOL; 2-(2-METHOXYETHOXY)ETHANOL Polypeptides Spike protein S1; Nanobody C1; BA.2-13 heavy chain; BA.2-13 light chain Oligo-state hetero-1-1-1-1-mer
	SMTL ID 8c3v.3 Ligands alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose; GLYCEROL; TETRAETHYLENE GLYCOL Polypeptides Spike protein S1; Nanobody C1; BA.2-13 heavy chain; BA.2-13 light chain Oligo-state hetero-1-1-1-1-mer